Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

8.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
8.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

404
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
404
Hazard Ratio01:12

Hazard Ratio

754
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
754
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

409
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
409
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

960
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
960

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emergency Physician and Emergency Nurse Communication in the Emergency Department: A Mixed-methods Study.

The western journal of emergency medicine·2026
Same author

Analyzing the Practice of Pediatric Infectious Diseases to Identify the Knowledge Tested on ABP Board Certification Exams.

Journal of the Pediatric Infectious Diseases Society·2025
Same author

A 4-Year Residency Program in Pediatrics/Global Child Health.

Pediatrics·2025
Same author

Distinguishing Multisystem Inflammatory Syndrome in Children From Typhus Using Artificial Intelligence: MIS-C Versus Endemic Typhus (AI-MET).

The Journal of infectious diseases·2025
Same author

Treating Pediatric Patients With HIV: We Can Still Do Better.

Pediatrics·2023
Same author

The Influence of a Wearable-Based Reward Program on Health Care Costs: Retrospective, Propensity Score-Matched Cohort Study.

Journal of medical Internet research·2023

Related Experiment Video

Updated: Apr 29, 2026

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
14:23

A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

Published on: August 31, 2014

15.2K

The Pediatric AIDS Corps: a 5-year evaluation.

Gordon E Schutze, Margaret G Ferris, David C Jones

    Pediatrics
    |May 28, 2014
    PubMed
    Summary

    The Pediatric AIDS Corps (PAC) significantly expanded HIV care for children and trained healthcare professionals in resource-limited areas. Its success supports developing a national global health corps program.

    More Related Videos

    New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
    09:27

    New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

    Published on: May 30, 2013

    10.6K
    Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
    07:10

    Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

    Published on: September 14, 2014

    13.8K

    Related Experiment Videos

    Last Updated: Apr 29, 2026

    A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
    14:23

    A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses

    Published on: August 31, 2014

    15.2K
    New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals
    09:27

    New Tools to Expand Regulatory T Cells from HIV-1-infected Individuals

    Published on: May 30, 2013

    10.6K
    Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
    07:10

    Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

    Published on: September 14, 2014

    13.8K

    Area of Science:

    • Global Health
    • Pediatric HIV/AIDS
    • Health Workforce Development

    Background:

    • The Pediatric AIDS Corps (PAC) was established in June 2005 by the Baylor College of Medicine International Pediatric AIDS Initiative.
    • This report details the PAC's activities and outcomes during its initial five years of operation.

    Purpose of the Study:

    • To describe the demographic characteristics and experiences of physicians participating in the Pediatric AIDS Corps.
    • To evaluate the impact of the PAC on HIV care and education in resource-limited settings.

    Main Methods:

    • Demographic data were collected for PAC physicians from July 2006 to June 2011.
    • A 21-question survey assessed physician experiences within the program.
    • Clinical and educational program data were also reviewed.

    Main Results:

    • 128 physicians served with the PAC, with a median tenure of 22.7 months.
    • 87% reported the experience influenced their future career choices, with half continuing work in resource-limited areas.
    • Enrollment of HIV-infected children increased from 6,107 to 103,731; approximately 500 local professionals received HIV training quarterly.
    • 37% of outreach sites became self-sufficient due to PAC physician mentoring.

    Conclusions:

    • Physician evaluations and program scale-up suggest the effectiveness of the PAC model.
    • Findings support the establishment of a national global health corps program to address healthcare needs in underserved regions.